Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to improved adverse effects for example drowsiness, although the clinical relevance is very low for most people – check the individual for adverse effects (e.If patient are not able to resume their standard oral medication